About Kowa

Kowa is a privately held multinational company headquartered in Nagoya, Japan. Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceuticals, life science, information technology, textiles, machinery and various consumer products. Kowa's pharmaceutical division is focused on research and development for cardiovascular therapeutics (dyslipidemia, type 2 diabetes, and atherosclerosis), ophthalmology and anti-inflammatory agents.
Global sales of the company's flagship product, pitavastatin (known as LIVALO and LIVAZO in different markets) was over 80 billion yen (US$800 million) in 2013.
For more information, please see http://www.kowa.co.jp/eng/.

Research Center for Advanced Science and Technology, The University of Tokyo,Fujitsu Limited,Kowa Company, Ltd.

All company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.

Date: 07 August, 2014
City: Tokyo and Nagoya, Japan
Company: Research Center for Advanced Science and Technology, The University of Tokyo, Fujitsu Limited, Kowa Company, Ltd.

distributed by